MetaVia
Social media
NEUROBO PHARMACEUTICALS INC Logo
Logos are displayed for identification only. Logokit is not affiliated with, endorsed by, or sponsored by the companies shown.
About NEUROBO PHARMACEUTICALS INC
MetaVia Inc is a clinical-stage biotechnology company focused on developing next-generation therapeutics for cardiometabolic diseases. The company is advancing DA-1726, a dual oxyntomodulin (OXM) analog agonist targeting GLP1R and GCGR for the treatment of obesity, and DA-1241, a GPR119 agonist for the treatment of metabolic dysfunction-associated steatohepatitis (MASH). MetaVia's pipeline aims to address significant unmet needs in obesity and liver disease through innovative drug development.
Year founded
2014
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Add MetaVia logo and brand data to your app or website
Embed this logo using a simple HTML tag, or access structured brand data with a single call to our API.
<img src="https://img.logokit.com/metaviatx.com" />
Report inaccurate data
Request an update to help us keep the brand up-to-date.
